Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial - PubMed (original) (raw)
Multicenter Study
Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial
Lynn E Eberly et al. Diabetes Care. 2006 Jan.
Abstract
Objective: To examine the long-term association of metabolic syndrome with mortality among those at high risk for cardiovascular disease (CVD).
Research design and methods: A total of 10,950 Multiple Risk Factor Intervention Trial (MRFIT) survivors were followed for mortality an additional median 18.4 years (1980-1999). Proportional hazards models examined multivariate-adjusted risks associated with Adult Treatment Panel III-defined metabolic syndrome conditions, with BMI substituted for waist circumference.
Results: At MRFIT annual visit 6, 4,588 (41.9%) men, mean age (+/-SD) 53.0 +/- 5.9 years, had metabolic syndrome and 6,362 did not. Comparing men with metabolic syndrome to men without, adjusted hazard ratios (HRs) were 1.21 (95% CI 1.13-1.29), 1.49 (1.35-1.64), and 1.51 (1.34-1.70) for 18-year total, CVD, and coronary heart disease mortality, respectively. Among men with metabolic syndrome, elevated glucose (1.54 [1.34-1.78]) and low HDL cholesterol (1.45 [1.17-1.54]) were most predictive of CVD mortality, followed by elevated BMI (1.34 [1.17-1.54]), elevated blood pressure (1.25 [0.98-1.58]), and elevated triglycerides (1.06 [0.86-1.30]). In contrast, for men without metabolic syndrome, the HR for low HDL cholesterol was 1.02 (0.86-1.22). Among metabolic syndrome men with no nonfatal CVD event, smokers with elevated LDL cholesterol showed higher CVD mortality (1.79 [1.22-2.63]) compared with nonsmokers without elevated LDL cholesterol; this additional risk was even greater for metabolic syndrome men with a nonfatal CVD event (2.11 [1.32-3.38]).
Conclusions: Metabolic syndrome is associated with an increased risk of mortality. Among those with metabolic syndrome, risk is further increased by having more metabolic syndrome conditions, by cigarette smoking, and by elevated LDL cholesterol. Primary prevention of each metabolic syndrome condition should be emphasized, and presence of each condition should be treated in accordance with current guidelines.
Similar articles
- The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. Lakka HM, et al. JAMA. 2002 Dec 4;288(21):2709-16. doi: 10.1001/jama.288.21.2709. JAMA. 2002. PMID: 12460094 - A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women.
Tonstad S, Hjermann I. Tonstad S, et al. J Cardiovasc Risk. 2003 Apr;10(2):129-35. doi: 10.1097/01.hjr.0000060837.46105.e7. J Cardiovasc Risk. 2003. PMID: 12668910 - [Gender difference in association between smoking and metabolic risks among community adults].
Wang JW, Hu DY, Sun YH, Wang JH, Xie J. Wang JW, et al. Zhonghua Yi Xue Za Zhi. 2011 Mar 29;91(12):805-9. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21600158 Chinese. - Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: the Oslo Study cohort.
Holme I, Tonstad S. Holme I, et al. Eur J Prev Cardiol. 2013 Feb;20(1):168-75. doi: 10.1177/1741826711432514. Epub 2011 Nov 30. Eur J Prev Cardiol. 2013. PMID: 22131130 - Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years. MRFIT Research Group.
Shaten BJ, Kuller LH, Neaton JD. Shaten BJ, et al. Prev Med. 1991 Sep;20(5):655-9. doi: 10.1016/0091-7435(91)90061-8. Prev Med. 1991. PMID: 1758844 Clinical Trial.
Cited by
- The tsim tsoum approaches for prevention of cardiovascular disease.
Singh RB, Demeester F, Wilczynska A. Singh RB, et al. Cardiol Res Pract. 2010;2010:824938. doi: 10.4061/2010/824938. Epub 2010 Jun 29. Cardiol Res Pract. 2010. PMID: 20671994 Free PMC article. - Statins and the primary prevention of cardiovascular events.
Clearfield M. Clearfield M. Curr Atheroscler Rep. 2006 Sep;8(5):390-6. doi: 10.1007/s11883-006-0036-6. Curr Atheroscler Rep. 2006. PMID: 16901409 Review. - ChaiQi Decoction Alleviates Vascular Endothelial Injury by Downregulating the Inflammatory Response in ApoE-Model Mice.
Wang B, Zhang J, Lu Y, Peng L, Yuan W, Zhao Y, Zhang L. Wang B, et al. Evid Based Complement Alternat Med. 2021 Feb 10;2021:9415819. doi: 10.1155/2021/9415819. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 33628325 Free PMC article. - Sensitivity, specificity, and predictive values of pediatric metabolic syndrome components in relation to adult metabolic syndrome: the Princeton LRC follow-up study.
Huang TT, Nansel TR, Belsheim AR, Morrison JA. Huang TT, et al. J Pediatr. 2008 Feb;152(2):185-90. doi: 10.1016/j.jpeds.2007.08.007. Epub 2007 Oct 22. J Pediatr. 2008. PMID: 18206687 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical